Skip to content

HELIPAQ CERECYTE CHE101020-30Recalls & reported problems

Medos International Sàrl · HELIPAQ microcoil HELIPAQ 10 CERECYTE Coil 10mm x 20cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00878528000624), received between Sep 6, 2017 and Sep 6, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Kinked” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Kinked1
  • Physical Resistance1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 6, 2017Kinked; Physical Resistance; Kinked; Physical Resistance

    AS REPORTED BY A HEALTHCARE PROFESSIONAL, DURING ANEURYSM COIL EMBOLIZATION, THEY TRIED TO INSERT THE HELIPAQ (CHE10102030/ C28384) COIL, BUT IT DID NOT PASS THROUGH THE UNSPECIFIED MICROCATHETER DESPITE SEVERAL ATTEMPTS AND DURING ANALYSIS IT WAS FOUND THAT THE COIL WAS KINKED. THERE WERE NO PATIENT ADVERSE EVENTS, BUT THE PROCEDURE WAS DELAY 15 MINUTES. THE PROCEDURE WAS COMPLETED WITH A SIMILAR PRODUCT. IT WAS REPORTED THAT THE DEVICE WOULD BE RETURNED FOR ANALYSIS.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6847319 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page